Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

7 Stocks to Buy to Ride the Vegan Wave

Plant-based foods have become big business in America. And these vegan stocks to buy show that America is crazy about meatless alternatives.

Is It Too Late to Buy Square After a 280% Gain?

Since the March lows, Square (NYSE:SQ) has mounted a tremendous comeback gaining more than 200%. Is it too late to buy SQ stock? 

Novavax at $200 a Pop by the End of 2020 Seems Like an Easy Target

Novavax (NASDAQ:NVAX) looks on its way to a credible vaccine. If so, NVAX stock going to $200 by the end of the years seems all but certain.  

Investing In Yonder Is Only More Valuable After the Coronavirus

If you’ve ever rented an Airbnb, here’s why you might want to invest in Yonder, the booking platform that lets you get away from it all.

If You’re Thinking About Betting on Lyft, Tesla Is a Wiser Choice

Some investors believe Tesla (NASDAQ:TSLA) is a better ride-hailing bet than Lyft (NASDAQ:LYFT). That’s bad news for Lyft stock. 

Whatever Happens to Inovio Pharmaceuticals, Insiders Will Do Just Fine

Inovio Pharmaceuticals' (NASDAQ:INO) insiders are benefitting from the novel coronavirus and the rise of INO stock.

9 Stocks for Beginners to Buy to Start Their Investing Experience

During the pandemic, some people have learned about investing to pass the time. That said, here are nine stocks for beginners to buy now.

Ford Needs a Plan to Keep Investors From Driving Away

Ford announces Q2 earnings July 30 after markets close. Will the report be bad enough to kill the momentum in F stock?

Cadence Makes Exclusivity a Bit More Accessible

It’s been a year since the launch of Cadence, the New York-based alternative investments platform. Here’s my Cadence review.

Sadly for Genius Brands, Where There’s Smoke, There’s Fire

Scott+Scott Attorneys at Law LLP are investigating possible misleading statements by Genius Brands (NASDAQ:GNUS). Should you sell GNUS stock?